A decentralized, nurse-led model of hepatitis C care with direct-acting antivirals was significantly effective and led to high levels of sustained virologic response in a large cohort of inmates, according to a recently published study.
“The prevalence of hepatitis C is higher in prisoners than in the general population, reflecting the criminalization of drug use and the frequent detention of [people who inject drugs (PWIDs)],” Timothy Papaluca, MBBS, FRACP, from the St Vincent’s Hospital and the University of Melbourne, Australia, and colleagues wrote. “This population has not typically been well engaged with specialist care, highlighting the need to develop new models of care for hepatitis C among marginalized, high transmitting populations.”
During a 13-month period, evaluation of 949 incarcerated patients revealed 562 patients eligible for treatment. Most of those deemed ineligible had an insufficient period of remaining incarceration to complete treatment.